Selank is a novel peptide anxiolytic drug. The name of the drug is an abbreviation of “selective anxiolytic”. It is used in Russia since 2009 for anxiety management.
Selank was developed at Zakusov Institute of Pharmacology, the same institute that developed Noopept, Afobazole, and Bromantane (Ladasten). By its structure, Selank is a derivative of Tuftsin, an endogenous peptide with immunostimulatory effect.
Besides pronounced anxiolytic action, the drug has nootropic, antidepressant, immunostimulant action and an excellent safety profile which is untypical for commonly used anxiety drugs.
Dosage and administration
Selank should be administered intranasally.
The dosage for people experiencing emotional stress is four drops in each nostril twice daily for 7 days.
The dosage for people recovering from infectious diseases and common cold, or experiencing chronic fatigue is four drops in each nostril once a day for 7 days.
For adaptation to significant mental loads (such as exams and stressful job), the dosage is four drops in each nostril once a day for 10 days.
The dosage for generalized anxiety disorder is three drops in each nostril three times a day for two weeks.
- Nasal irritation during long-term use
- Pregnancy and lactation